Under the Emergency Use Authorization (EUA), COVID-19 vaccination is indicated only for 18 years and above.
Co-administration of vaccines
If required, COVID-19 vaccine and other vaccines should be separated by an interval of at least 14 days
Interchangeability of COVID-19 Vaccines is not permitted : Second dose should also be of the same COVID-19 vaccine which was administered as the first dose.
Persons with history of :
Anaphylactic or allergic reaction to a pervious dose of COVID-19 vaccine
Immediate or delayed-onset anaphylaxis or allergic reaction to vaccines or injectable therapies, pharmaceutical products, food-items etc.
Pregnancy & Lactation :
Pregnant & Lactating women have not been part of any COVID-19 vaccine clinical trial so far. Therefore, women who are pregnant or not sure of their pregnancy: and lactating women should not receive COVID-19 vaccine at this time
Provisional/temporary contraindications: In these conditions, COVID vaccination is to be deferred for 4-8 weeks after recovery
Persons having active symptoms of SARS-CoV-2 infection.
SARS-CoV-2 patients who have been given anti-SARS-CoV-2 monoclonal antibodies or convalescent plasma
Acutely unwell and hospitalized (with or without intensive care) patients due to any illnes
Vaccine should be administered with caution in persons with history of any bleeding or coagulation disorder (e.g., clotting factor deficiency, coagulapathy of platelet disorder).
Following conditions are not contraindicated for COVID vaccines
Persons with past history of SARS-CoV-2 infection (sero-positivity) and or RT-PCR positive illness
History of chronic diseases and morbidities (cardiac, neurological, pulmonary, metabolic, renal, maliganancies)
Immuno-deficiency, HIV, patients on immune-suppressio due to any condition (the response to the COVID 19 vaccines may be less in these individuals)
Other Important Issues to Consider
Vaccine specific contraindications may apply as the new information becomes available.